ArticleNeurological research and practice2026
CTA imaging characteristics and endovascular therapy effect in patients with large ischemic stroke: a prospective cohort study.
Article in Neurological research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundAlthough landmark trials showed favorable outcomes with endovascular therapy (EVT) for large ischemic stroke, imaging protocols for patient inclusion varied. This study aims to explore the interaction between computed tomography angiography (CTA) imaging characteristics and the association of EVT with outcomes in real-world clinical practice.
methodsThis was a subanalysis of a prospective cohort study that enrolled patients with large vessel occlusion and ASPECTS 0–5 from 38 stroke centers across China between November 2021 and February 2023. Based on admission CTA imaging, the occlusion site, Tan score, cortical vein opacification score (COVES), internal cerebral veins (ICV), and clot burden score were assessed. The primary outcome was the 90-day modified Rankin Scale (mRS). Treatment effects across subgroups based on CTA imaging characteristics were analyzed using ordinal regression analysis, and interaction analysis was performed to assess whether these characteristics modified the effect of EVT on 90-day mRS.
resultsAmong the 460 patients (255 male, 55.4%), the EVT group was younger than SMT group (67 years [IQR, 58–77] vs. 72 years [IQR, 65–79]). COVES and Tan score significantly modified the association between EVT and 90-day mRS (P < 0.001 and P = 0.023 for interaction, respectively), with a larger effect size observed in patients with COVES 3–6 (adjusted common odds ratio [acOR], 2.43 [95% CI, 1.39–4.27]; P = 0.002) and Tan score 2–3 (acOR, 2.78 [95% CI, 1.24–6.24]; P = 0.013). In contrast, occlusion site, ICV score, and clot burden score did not modify the effect of EVT.
conclusionBetter arterial and venous collaterals in patients with large ischemic stroke are associated with favorable outcomes and may modify the effect of EVT. This analysis provides preliminary evidence supporting the role of baseline CTA imaging in guiding EVT selection for these patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.